NDC 0074-1825 - Novocain

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC: 0074-1825
Package NDCs from labels: 0074-1825-30
Manufacturer: Hospira, Inc.
Effective date: 2007-04-16
Current FDA listing: Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
Label	Manufacturer	Effective date	Type
NOVOCAIN ® PROCAINE HYDROCHLORIDE INJECTION, USP	Hospira, Inc.	2007-04-16	Human prescription drug label

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
0074-1825-30	Novocain	1 in 1 CARTON	INJECTION, SOLUTION	1		1
0074-1825-30	Novocain	100 in 1 CASE	INJECTION, SOLUTION	100		1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
0074-1825	NOVOCAIN (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.]	1	2 package rows	20070426_C80C810A-60E0-49BD-139C-95AEC3A286FC.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
Procaine Hydrochloride	ACTIVE INGREDIENT	95URV01IDQ	NOVOCAIN (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.]	1
Procaine	ACTIVE MOIETY	4Z8Y51M438	NOVOCAIN (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.]	1
Acetone Sodium Bisulfite	INACTIVE INGREDIENT		NOVOCAIN (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.]	1
Chlorobutanol	INACTIVE INGREDIENT	HM4YQM8WRC	NOVOCAIN (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.]	1
Hydrochloric Acid	INACTIVE INGREDIENT	QTT17582CB	NOVOCAIN (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.]	1
Sodium Chloride	INACTIVE INGREDIENT	451W47IQ8X	NOVOCAIN (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.]	1
Sodium Hydroxide	INACTIVE INGREDIENT	55X04QC32I	NOVOCAIN (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.]	1

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 3 of 13 · 253 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Marcaine	BUPIVACAINE HYDROCHLORIDE	Hospira, Inc.	67578b56-7540-487e-1fba-481255620e78	2026-05-29	Boxed warning, Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.
Plegisol	POTASSIUM CHLORIDE, SODIUM CHLORIDE, CALCIUM CHLORIDE, AND MAGNESIUM CHLORIDE	Hospira, Inc.	35a174f0-f0d7-4ec7-3f81-d3d572c059cf	2026-05-27	Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.
THAM	TROMETHAMINE	Hospira, Inc.	4af52118-c12b-4ad5-30bb-959848357e8a	2026-05-27	Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.
Naloxone Hydrochloride	NALOXONE HYDROCHLORIDE	Hospira, Inc.	8535cc84-ad4a-4d67-8480-fb5a2e3406f8	2026-05-27	Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.
DOBUTAMINE	DOBUTAMINE	Hospira, Inc.	89becb0c-da60-4f43-0a98-29ff7a9eca58	2026-05-27	Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.
TPN Electrolytes	SODIUM CHLORIDE, CALCIUM CHLORIDE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE, AND SODIUM ACETATE ANHYDROUS	Hospira, Inc.	c00817bc-7b62-4abe-0280-e7930eda3f94	2026-05-25	Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.
Cisatracurium Besylate	CISATRACURIUM BESYLATE	Hospira, Inc.	67908e20-044d-454d-9c51-bf106e817bd0	2026-05-25	Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.
Heparin Sodium and Dextrose	HEPARIN SODIUM	Hospira, Inc.	eede8a0c-5ae6-4166-84b3-12081405f08e	2026-05-25	Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.
Diltiazem Hydrochloride	DILTIAZEM HYDROCHLORIDE	Hospira, Inc.	bba03666-ff4f-4bf6-fa92-78e1ec2d9073	2026-05-24	Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.
Ondansetron	ONDANSETRON	Hospira, Inc.	d62cd60b-f87e-4825-bead-1d18bbc4e480	2026-05-23	Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.
Lidocaine Hydrochloride	LIDOCAINE HYDROCHLORIDE	Hospira, Inc.	89a4bd73-89f4-4fd7-2c9f-921e1da8f96b	2026-05-22	Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.
Diazepam	DIAZEPAM	Hospira, Inc.	7e7dd743-a87b-4ab3-b6ae-f116cd0c8b0f	2026-05-22	Boxed warning, Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.
Acetylcysteine	ACETYLCYSTEINE	Hospira, Inc.	5558a5f5-e821-473b-7d8a-5d33d09f0586	2026-05-22	Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.
LMD in Dextrose	DEXTRAN 40	Hospira, Inc.	3c273512-84e2-2cea-b201-12345a6bd1fe	2026-05-22	Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.
Aminophylline	AMINOPHYLLINE	Hospira, Inc.	9a663ef3-881f-48bd-2689-3713b24545c2	2026-05-22	Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.
Ondansetron	ONDANSETRON	Hospira, Inc.	6a11f61b-2318-4382-2b91-4366e4bb53fa	2026-05-22	Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.
Bacteriostatic Water	BACTERIOSTATIC WATER	Hospira, Inc.	87d6e9dc-fe3b-4593-ac9a-d7493d1959c7	2026-05-22	Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.
Metoprolol Tartrate	METOPROLOL TARTRATE	Hospira, Inc.	7c1f998a-233d-4feb-6ea2-457702abd0d2	2026-05-21	Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.
Gentamicin Sulfate	GENTAMICIN SULFATE	Hospira, Inc.	977180b3-a222-4282-d485-4a3217674305	2026-05-20	Boxed warning, Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.
Precedex	DEXMEDETOMIDINE HYDROCHLORIDE	Hospira, Inc.	548a88c0-afda-427e-75ac-5af0cfa2224c	2026-05-20	Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.